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Abstract 
Plants growing in the Judea region are widely used in traditional medicine of the Levant region. Nevertheless, 
they have not so far been sufficiently analyzed and their medicinal potential has not been evaluated. This study 
is the first attempt to fill the gap in the knowledge of the plants growing in the region. Comprehensive data 
mining of online botanical databases and peer-reviewed scientific literature including ethno-pharmacological 
surveys from the Levant region was applied to compile a full list of plants growing in the Judea region, with 
the focus on their medicinal applications. Around 1300 plants growing in the Judea region were identified. Of 
them, 25% have medicinal applications which were analyzed in this study. Screening for chemical-protein 
interactions, together with the network-based analysis of potential targets, will facilitate discovery and 
therapeutic applications of the Judea region plants. Such an approach could also be applied as an integrative 
platform for further searching the potential therapeutic targets of plants growing in other regions of the world. 
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1 Introduction 
Humans have used plants as therapeutic agents from pre-historic times (Solecki and Shanidar, 1975). Since 
then, out of estimated 250,000 flowering plant species in the world (Cronquist, 1981), 15% have been 
evaluated phytochemically and only 6% have been screened for biological activity (Verpoorte, 2000). While a 
relatively small portion of all plants have been used for medicinal purposes, their importance should not be 
undermined as almost 65% of the world’s population has incorporated them into their primary modality of 
health care (Farnsworth et al., 1985). Moreover, the use of medicinal plants has brought a number of clear-cut 
benefits including (i) isolation of compounds that nowadays are used as drugs (e.g., digoxin, morphine, taxol); 
(ii) synthesis of new compounds possessing higher activity and/or lower toxicity than the parent compounds 
found in medicinal plants (e.g., metformin, verapamil, and amiodarone which are based, respectively, on 
galegine, podophyllotoxin, and khellin); (iii) application of the agents from plants as tools for pharmacological 
research (e.g., mescaline, yohimbine); and, finally, (iv) using the whole plant or its parts as an approved herbal 
remedy (e.g., echinacea, garlic, ginkgo biloba, St. John’s wort, and many others) (reviewed by Fabricant and 
Farnsworth, 2001). Network Biology, 2012, 2(3):84-94 
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The important point is that ethno-medical information could facilitate the discovery of new drugs by 
providing a preliminary list of most promising candidate plants for further investigation. Besides shortening 
the pipeline to drug discovery, using the plants as a starting point has another advantage of potentially reducing 
the toxic side effects, since active compounds from the plants used by humans are likely to be safer than those 
with no history of human use. 
    In particular, in the Levant region, plants were the dominant source of medicaments over thousands of 
years as supported by the medical tradition (Lev, 2002). Remarkably, out of more than 200 traditionally used 
medicinal plants, 90.5% were native to the Levant (Lev, 2002). In case of the Land of Israel, located in the 
heart of the Levant, the combined influence of the Mediterranean as a moderating factor and the deserts as a 
drying factor contribute to the country’s floral diversity (Lev and Amar, 2000). Also, the unique geographical 
location of Israel between three continents, and its position on the major trading routes between Mesopotamia 
and Egypt, and between Arabia and Europe, has enriched the country’s inventory of medicinal materials. As a 
result, a variety of medicinal plants were exported from cultures such as Egypt, Assyria, Babylon, India, China, 
and later from Europe and Americas. Collectively, out of more than 2,600 plant species growing in Israel, 700 
are noted for their uses as medicinal herbs or as botanical pesticides (Said et al, 2002). The large number of 
herbal remedies reflects the high extent of ethno-medical knowledge accumulated in Israel (Silva & Avraham, 
1981; Friedman et al, 1986; Ali-Shtayeh et al, 2000).   
    Among various phytogeographic zones found in Levant, the Judea region stands out in its unique 
biodiversity. The Judea region is situated between the Judean Hills, with an elevation of up to 1000 m above 
sea level and a rainy Mediterranean climate, and the Dead Sea which is the lowest place on earth ― more than 
400 m below sea level, with constantly warm and dry conditions. 
    These two climatic extremes are separated by a narrow strip of only 30 km in width. A strong climatic 
gradient, results in generation of highly stressful conditions. As a consequence of this permanent stress, both 
endemic and widely distributed Mediterranean plants growing in the area have unique chemotypes, in 
particular, accumulate relatively high levels of certain phytosteroids (Tamir et al., 2011). Highly valuable and 
well-studied medicinal plants such as Jericho balsam (Balanites aegyptiaca), ben tree (Moringa peregrina), 
Dead Sea apple (Solanum incanum), sebesten (Cordia myxa), and gum arabic (Acacia senegal) grow in the 
vicinity of the Dead Sea Valley, the eastern part of the Judea region (Lev, 2002). 
    While it is clear that the Judea region is a biodiversity spot and a valuable resource of plants with 
potential use in medicine, to the best of our knowledge, no ethno-pharmacological study has thus far been 
carried out to assess the folk uses of the local vegetation. This gap could be partially closed by collecting data 
from the ethno-botanical surveys performed in vicinity of the Judea region, the other regions of Israel (Ali-
Shtayeh et al., 2008; Said et al., 2002; Ali-Shtayeh et al., 2000; Lev & Amar, 2000; Friedman et al., 1986; 
Dafni et al., 1984) and the neighboring Levant countries (Alzweiri et al., 2011; Al-Quran, 2009; Hudaib et al., 
2008; Al-Quran, 2006; Al-Quran, 2005; Aburjai et al., 2007; Alachkar et al., 2011). Furthermore, this data 
could be complemented and integrated with peer-reviewed modern scientific literature dealing with medicinal 
uses of herbal extracts and/or selected compounds isolated from the plants growing in the Judea region. With 
this in mind, we have carried out comprehensive data mining of the plants growing in the Judea region, 
identified those with medicinal uses, and analyzed potential therapeutic targets for the selected plants, using a 
network-based approach. 
 
2 Methods 
The list of the plants growing in the Judea region (Judea Mountains, Judea Desert and Dead Sea Valley) was 
extracted from the Wild Flowers of Israel (http://www.wildflowers.co.il) and Flora of Israel Online 
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(http://flora.huji.ac.il) databases. An extensive data mining of scientific literature and ethno-pharmacological 
surveys was carried out to identify medicinal applications of the local vegetation (Fig. 1).   
 
 
 
     
Fig. 1 Workflow of extraction of Judea region plants and their medicinal applications. 
 
 
The validated and potential human targets of the major compounds found in the medicinal plants were 
downloaded from the STITCH database (Kuhn et al., 2010; http://stitch.embl.de/), one of the largest 
repositories of chemical-protein interactions. The NetAge database (Tacutu et al., 2010; http://netage-
project.org/) was applied to data mine association of the medicinal plants targets with the major human age-
related diseases and associated processes. Protein-protein interaction (PPI) data for the targets was extracted 
from the BioGRID database (Stark et al., 2011; http://thebiogrid.org; human interactome release 3.1.71). The 
graphical output of the PPI networks between the targets of the herbal compounds was generated using Osprey 
(Breitkreutz et al., 2003; http://biodata.mshri.on.ca/osprey/servlet/Index).   
 
3 Results and Discussion 
3.1 Judean plants and their medicinal applications 
The combined dataset of the plants growing in the Judea region (Judea Mountains, Judea Desert and Dead Sea 
valley) contains 1291 plant species belonging to 102 botanical families (Online Suppl Table1). For each plant 
entry, the scientific name, common name, botanical family, distribution in Israel, medicinal uses along with 
literature references (where available) are indicated. A remarkably high percent of plants growing in the Judea 
region (332 plants, 25% of the collected species) has been reported to have medicinal uses. Analysis of the 
medicinal plants showed that almost half of them (45%) have anti-microbial activity, and a considerable 
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portion exerted anti-inflammatory, anti-cancer, anti-oxidant and anti-diabetic action (31%, 31%, 29%, and 
22%, respectively) (Fig. 2). Other less frequent uses include modulation of the wound healing response, 
neuroprotective, immunomodulatory, diuretic, hypotensive and hypolipidaemic effects and 
treatment/prevention of various pathological conditions of the internal organs.   
 
 
Fig. 2 Distribution of the medicinal plants growing in the Judea region by their major therapeutic applications. 
 
 
        Apart from the plants reported for having only one therapeutic application (about 40%), many are known 
for their pleiotropic mode of action. For example, approximately 35% of the Judean medicinal plants have at 
least three therapeutic applications. This finding is not surprising as medicinal plants contain complex mixtures 
of active compounds that simultaneously act on hundreds of targets in the human genome (Schmidt et al., 
2008). Another important point is that secondary compounds in plants may synergize the primary active 
compounds and also ease their possible side effects (Wink, 2008).   
3.2 Chemical composition of Judean plants: importance of chemotypes   
The clue to understanding of the mechanisms of medicinal plant therapeutic activities lies in deciphering their 
chemical composition. Only several plant samples originally growing in the Judea region have so far been 
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analyzed for their chemical composition (Gorelick et al., 2011; Tamir et al., 2011). Nevertheless, considerable 
amount of data could be extracted from the scientific reports (430 reports in total) on Judean plants growing in 
neighboring as well as in other regions of the globe. Up to date, chemical compositions of 189 out of 332 (57%) 
local medicinal species have been analyzed. These reports are summarized in Online Suppl Table 2. For each 
chemical composition entry, the plant part from which the whole extracts and/or selected compounds were 
extracted, country of origin and link to the original work were indicated. The distribution of the collected 
chemical composition reports around the World supported importance of the examined plants in Levant's 
medical tradition. Around third (31%) of the analyzed plant specimens came from the Middle East, while 
another considerable portion of studies were carried out in the neighboring regions of Mediterranean Europe 
and North Africa (23% and 8%, respectively). 
    An important point is that plant populations belonging to the same species may differ in their chemical 
compositions (chemotypes) (Barra, 2009). For example, Varthemia (Chiliadenus) iphionoides, an endemic 
shrub of the eastern Mediterranean, which possesses cytotoxic, anti-oxidant, anti-diabetic and anti-bacterial 
activities (Al-Dabbas et al, 2006; Gorelick et al., 2011) was shown to have three major chemotypes in Israel, 
primarily associated with variations in the content of essential oils (Tamar et al., 2011). According to the 
dominant constituents, V. iphinoides chemotypes are divided into chemotype A (camphor/alpha-
pinene/fokienol), chemotype B (t-cadinol/1,8-cineole/trans-chrysanthemol), and chemotype C (intermedeol). 
The distribution of the above chemotypes varies within Israel along the north-south axis, with the chemotype 
A increasing southward and the chemotype B increasing northward. 
        The difference in the chemical composition might have a deep impact on the effectiveness and suitability 
of a given vegetative population for medicinal uses. In case of V. iphinoides, intermedeol (chemotype C) was 
shown to be effective as a mosquito repellant (Cantrell et al., 2005) and holds therapeutic potential for the 
treatment of human leukemia (Jeong et al., 2002). The t-cadinol (chemotype B) has muscle-relaxing potential 
(Zygmunt et al., 1993) and may also be useful in immunotherapy (Takei et al., 2006). The alpha-pinene, one of 
the dominant compounds of the typical to the Judea region chemotype A, was shown to exert anti-cancer 
action in both in vitro and in vivo models (Neves et al., 2010). The alpha-pinene induced apoptosis in B16F10 
murine melanoma cell line and inhibited the metastasis of melanoma in mice. Its potent anti-inflammatory 
activity was demonstrated on IL-1-treated human articular chondrocytes (Neves et al., 2010). The authors 
showed that a fraction containing 93% alpha-pinene prevented IL-1-induced NO production and reduced 
significantly the IL-1-induced degradation of IκB which inhibits the pro-inflammatory NF-κB transcription 
factor, in particular, through blocking its DNA-binding activity. 
3.3 Identifying the human targets of herbal compounds 
Up to date, a great amount of data on chemical-protein interactions has been accumulated. This knowledge 
could allow for identifying potential human targets of the chemicals found in the local plants. Such an 
approach combined with the data on the involvement of these targets in various diseases and pathological 
conditions could be helpful (i) for clarifying the mechanisms of therapeutic action of the already established 
medicinal plants including those growing in the Judea region; (ii) for predicting their new therapeutic 
applications; and (iii) for selecting the most promising plant candidates for further experimental and clinical 
examination. 
    Taking this into account, we have identified human targets of the major compounds found in the V. 
iphinoides chemotypes. Altogether, we identified 67 human targets of camphor, 59 targets of alpha pinene, 41 
targets of 1,8-cineole, and 2 targets of chrysemantol. Using the NetAge database, a compendium of networks 
for longevity, age-related diseases and associated processes (Tacutu et al., 2010; http://netage-project.org/), we 
further data mined association of the targets of the major compounds found in the V. iphinoides chemotype A 
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(typical to the Judea region) with various human pathologies. In total, 23 targets (13 of camphor and 10 of 
alpha-pinene) were reported as being involved in at least one age-related pathological condition (Table 1). As 
seen in Table 1, the majority of the target proteins are associated with cancer. Notably, several of them (e.g., 
AR, COL18A1, CYP1A1, ESR1, and NCOA1) are also involved in other age-related diseases and processes, 
thus possessing a potential for pleiotropic action. Some of the found targets and their interactions may, at least 
in part, explain the already acknowledged anti-diabetic (Gorelick et al., 2011), anti-oxidant (Al-Mustafa and 
Al-Thunibat, 2008), and anti-cancer (Al-Dabbas et al., 2006) activities of V. iphinoides extracts. For example, 
the alpha-pinene-containing chemotype might exert its anti-cancer activity through inhibition of oncogenes 
(HRAS, GNAS), and anti-inflammatory activities through inhibition of pro-inflammatory molecule NFKBIA 
(Giehl, 2005) (Table 1). Consequently, it is plausible to suggest that the alpha-pinene anti-inflammatory 
activities are mediated through inhibition of NF-κB, as has directly been shown in IL-1-treated human articular 
chondrocytes (Neves et al., 2010). Another camphor target molecule with pleiotropic activity is the steroid 
receptor co-activator NCOA1 (SRC1), one of the key downstream sensors of environmental signals (Lonard et 
al., 2010; York and O'Malley, 2010), shown to be involved in carcinogenesis, type 2 diabetes, oxidative stress, 
and chronic inflammation (Tacutu et al., 2010).   
The network-based approach is becoming increasingly used as a systems biology tool to investigate 
complex biological processes including aging, age-related diseases and various pathologies (Budovsky et al., 
2007; Wolfson et al., 2009; Ibrahim et al., 2011; Tacutu et al., 2010, 2011a,b; Zang, 2011; Zhang, 2012a,b; 
Moskalev et al., 2012). As shown by us and others (Goh et al. 2007), analysis of interactions between proteins 
involved in various diseases may provide new insights into their etiology and the links between them. With 
this in mind, we examined the protein-protein interactions (PPIs) between targets of major V. iphinoides 
compounds. In case of camphor, we found 12 interacting protein targets, of them, 8 proteins form a small PPI 
network (Fig. 3A). Interestingly, the central node of this network – steroid receptor co-activator NCOA1 
(SRC1) has been suggested to be one of the central downstream sensors in various human polygenic diseases 
(Lonard et al., 2010; York and O'Malley, 2010). In support of this notion are more than 40 PPIs of NCOA1, 
connecting it to other major proteins involved in human pathologies, such as AR, ESR1, FOS, JUN, etc. (data 
not shown). Though the targets of alpha-pinene and 1,8-cineole do not interact between themselves, they do 
form several continuous PPI networks, when their first-order interacting partners were added (Fig. 3 B and C). 
Collectively, these networks contain around 200 proteins. Among them are 26 targets of alpha-pinene and 20 
targets of 1,8-cineole, which interact with a number of important disease-associated genes/proteins (see the 
NetAge database for disease-association annotations). Thus, pleotropic action of V. iphinoides extracts could 
be explained by their effect on highly connected nodes of the human interactome. In this context, it is 
reasonable to suggest that the multi-target herbal therapies might be superior to conventional agents that affect 
only one target at a time (Csermely et al., 2005). Specifically, from the network-based perspective, partial 
inhibition of several targets could be more efficient than the complete inhibition of a single target, making the 
plant extracts a promising category for developing next generation of pharmacological agents with pleiotropic 
mode of action. 
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Table 1 The targets of major compounds found in the V. iphinoides chemotype A and their involvement in human 
age-related diseases and processes. 
 
 
 
Compound Target  Cancer  Atherosclerosis Type 2 
diabetes
Alzheimer’s
disease 
Oxidative 
stress 
Chronic  
inflammation
Camphor ACPP   
AR 
CAMP 
COL18A1 
ESR1  
F8  
HNF4A  
KRIT1 
NCOA1  
NR3C1 
PGR  
SPEN  
YES1 
+ 
+ 
 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
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+ 
+ 
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Alpha-pinene CYP1A1 
GNAS 
HRAS 
KLK10 
LHCGR   
NFKBIA 
SAGE1   
SLC6A4 
SPEN  
TYR 
+ 
+ 
+ 
+ 
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+ 
+ 
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+ 
+  
 
 
 
 
+ 
A 
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Fig. 3 Graphical output of the direct protein-protein interactions (PPIs) between human targets of the major compounds found in 
the V. iphinoides chemotypes. (A) PPIs between camphor targets. (B) PPIs between alpha-pinene targets including their first-
order partners. (C) PPIs between 1,8-cineole targets including their first-order partners. 
 
B 
C 
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4 Concluding Remarks 
The great medicinal potential of the plants growing in Judea is only beginning to be unveiled. This work serves 
as a first assessment of the unique flora found in this region. That being said, it is important to note that the 
application of network biology (holistic) approach to the study of the medicinal plants has great advantages 
over the conventional “one target at a time” attitude.   
        The collected dataset provides information to what extent the plants growing in the Judea region are used 
medicinally. This information may open new avenues for investigation aimed at rational and directed 
screening of potential plant species for biological activities. Importantly, such screening could be carried out in 
a planned rather than random manner, thus saving time, money and other valuable resources.   
    The collected data may also be used to predict medicinal uses of additional Judean plants and new 
applications for the already confirmed plants. This goal could be achieved by examination of common 
compounds and, subsequently, common human targets. This is also true in case of plants with a known 
chemical composition but without any evidence for biological activity.     
Given the deep links between complex poly-genetic human diseases, especially those with age component 
(Tacutu et al., 2010), plant materials already known to be effective against at least one of these diseases are 
more likely to be active against the others. This could be clearly seen from the list of Judea plants medicinal 
applications. For example, in many cases, plants active against diabetes were also active against 
atherosclerosis, cancer and chronic inflammation and vice versa (Online Suppl Table 1). Screening for 
chemical-protein interactions together with the network-based analysis of potential targets will facilitate 
discovery and therapeutic applications of the Judea region plants. Such an approach could also be applied for 
searching the potential therapeutic targets of plants growing in other regions of the world, in particular those 
with an ancient folk medicine tradition, such as China and India. 
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